
78.99 Delayed Data As of Dec 08 | ![]() Today’s Change | 72.87 Today|||52-Week Range 89.74 | -7.99% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $98.5B |
Gilead Sciences, Inc. 333 Lakeside Drive Foster City California 94404 |
Daniel P. O'Day | Chairman & Chief Executive Officer |
Andrew D. Dickinson | Chief Financial Officer |
Merdad V. Parsey | Chief Medical Officer |
Flavius Martin | Executive Vice President-Research |
Sandra K. Patterson | SVP, Chief Accounting Officer & Controller |